[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336124-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336124-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-durability-of-previous-examinations-for-cancer-danish-nationwide-cohort-study","The durability of previous examinations for cancer - Danish nationwide cohort study","","Patients with an earlier negative cancer examination may later consult general practice for ongoing or new symptoms suggestive of cancer. This study investigates whether a sufficiently safe post-examination period exists after negative results for lung (CT thorax), upper gastrointestinal (gastroscopy), colorectal (colonoscopy), bladder (cystoscopy), and breast (clinical mammography) cancer examinations. Danish register-based time-to-event analyses use follow-up to estimate age- and sex-adjusted hazard ratios for cancer diagnosis after negative examinations versus non-examined individuals.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-durability-of-previous-examinations-for-cancer-danish-nationwide-cohort-study/336124/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-durability-of-previous-examinations-for-cancer-danish-nationwide-cohort-study/336124.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address after a negative cancer examination?","Question",{"text":63,"@type":64},"It examines whether there is a relatively safe period during which the risk of later cancer after a negative result is sufficiently low for different cancer types to be ruled out.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which cancer types and corresponding examinations were included?",{"text":68,"@type":64},"Lung (CT thorax), upper gastrointestinal (gastroscopy), colorectal (colonoscopy), bladder (cystoscopy), and breast (clinical mammography) were assessed alongside their respective examinations.",{"name":70,"@type":61,"acceptedAnswer":71},"How did the study estimate risk after negative examination results?",{"text":72,"@type":64},"It used register-based time-to-event analyses and, with a 1-year follow-up, calculated age- and sex-adjusted hazard ratios for cancer diagnosis after negative examinations, with non-examined individuals as the reference group.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336124,1790472561,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":118,"preview_page_count":4},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Scandinavian Journal of Primary HealtH care 2024, vol. 42, no. 2, 246–253  \n[https://doi.org/10.1080/02813432.2024.2305942](https://doi.org/10.1080/02813432.2024.2305942)  \nReseaRch aRticle    \nThe durability of previous examinations for cancer: Danish nationwide cohort study  \nJesper lykkegaard , Jonas Kanstrup Olsen , sonja Wehberg  and Dorte ejg Jarbøl  research unit for General Practice, department of Public Health, university of Southern denmark, odense, denmark  \nABSTRACT  \nObjective: Patients previously examined for cancer with a negative result may present in general practice with ongoing or new symptoms or signs suggestive of cancer. this paper explores the potential existence of a relatively safe period for cancer occurrence after receiving negative examination results for specific types of cancer, including lung (ct thorax), upper gastrointestinal (gastroscopy), colorectal (colonoscopy), bladder (cystoscopy), and breast (clinical mammography). Design: Register-based time-to-event analyses.  \nSetting: Denmark.  \nSubjects: all 3.3 million citizens aged 30–85 years who on January first, 2017, had not previously been diagnosed with the specific type of cancer were categorized based on the time since their most recent examination.  \nMain outcome measures: Using 1-year follow-up, we calculated the age- and sex-adjusted hazard ratios of being diagnosed with the related cancer, with non-examined individuals as reference. Negative examination results were defined as the absence of a cancer diagnosis within 6 months following the examination.  \nResults: Previous negative examination results were common, also among those diagnosed with cancer during follow-up. For 10 years after a negative colonoscopy the risk of diagnosing a colorectal cancer was nearly halved. however, already 1 year after a clinical mammography and 2 years after a ct thorax the risk of diagnosing the related cancers was significantly higher among those with a previous negative result compared to non-examined individuals. Conclusion: this study did not identify a post-examination period in which the cancer risk, compared to non-examined individuals, was sufficiently low to confidently rule out any of the investigated cancers.  \nKEY POINTS  \nWhat should one expect when considering re-examining a patient with a negative result of a previous examination for cancer? We found that previous negative examination results are common in the general population and among those subsequently diagnosed with cancer. We did not find a safe period after any of the examinations in which a negative result alone could safely rule out the presence of cancer.  \nARTICLE HISTORY  \nReceived 11 august 2023 accepted 10 January 2024  \nKEYWORDS  \n(Mesh): early Detection of cancer; Diagnostic imaging; endoscopy; epidemiology;  \nReproducibility of results; General practice  \nIntroduction  \ncertain examinations, such as computer tomography (ct) of the thorax for lung cancer [1], gastroscopy for upper gastrointestinal cancer [2], colonoscopy for colorectal cancer [3], cystoscopy for bladder cancer [4], and clinical mammography for breast cancer [5] are recognized for their effectiveness in detecting the respective cancer types if present. however, patients  \nwho have previously undergone these examinationsand received negative results, indicating the absence of cancer, may subsequently present in general practice with ongoing or new symptoms or signs suggestive of a missed or new developed cancer. this poses a challenge for general practitioners (GPs) who must make decisions regarding whether to repeat the examination and, if not, how long to rely on the negative result. Diagnostic considerations include the possibility  \nCONTACT Jesper lykkegaard  [jlykkegaard@health.sdu.dk](jlykkegaard@health.sdu.dk)  research unit for General Practice, department of Public Health, university of Southern denmark, JB Winsløws vej 9a, dK-5000, odense, denmark.  \n Supplemental data for this article can be acc","cbCaib7J9vih1b3r","https://ap.wps.com/l/cbCaib7J9vih1b3r","pdf",1361624,"English","# Abstract\n# Key points\n# Introduction\n# Methods\n## Design and population","[{\"question\":\"What question does the study address after a negative cancer examination?\",\"answer\":\"It examines whether there is a relatively safe period during which the risk of later cancer after a negative result is sufficiently low for different cancer types to be ruled out.\"},{\"question\":\"Which cancer types and corresponding examinations were included?\",\"answer\":\"Lung (CT thorax), upper gastrointestinal (gastroscopy), colorectal (colonoscopy), bladder (cystoscopy), and breast (clinical mammography) were assessed alongside their respective examinations.\"},{\"question\":\"How did the study estimate risk after negative examination results?\",\"answer\":\"It used register-based time-to-event analyses and, with a 1-year follow-up, calculated age- and sex-adjusted hazard ratios for cancer diagnosis after negative examinations, with non-examined individuals as the reference group.\"}]","The durability of previous examinations for cancer - Danish nationwide cohort study | PDF",1790013671]